Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-335002 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 5, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
81,000
Total Value
$875,917.41
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D | Common Stock | โ | Aug 3, 2026 | Exercise/Conversion | 27,000 | $5.20 | $140,400.00 | 142,743 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Aug 3, 2026 | Sale | 5,267 | $26.79 | $141,100.30 | 137,476 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Aug 3, 2026 | Sale | 21,733 | $27.35 | $594,417.11 | 115,743 | Direct | โ | View Details | |
President, R&D | Stock Option (Right to Buy) | Derivative | Aug 3, 2026 | Exercise/Conversion | 27,000 | $0.00 | $0.00 | 287,040 | Direct | โ | View Details |